Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 76 entries
Sorted by: Best Match Show Resources per page
Direct determination of oxygen by HPLC. 2. Chamber and sample application system for determination of o(2) at trace levels.

Analytical chemistry

Seppi T, Stubauer G, Obendorf D, Lukas P.
PMID: 21639180
Anal Chem. 1997 Nov 01;69(21):4476-81. doi: 10.1021/ac970364i.

All oxygen measurement systems so far available are characterized by a lack of suitable precision and/or required limit of detection, which would be essential for a great variety of applications. In this paper, a novel oxygen chamber together with...

Cite
Seppi T, Stubauer G, Obendorf D, et al. Direct determination of oxygen by HPLC. 2. Chamber and sample application system for determination of o(2) at trace levels. Anal Chem. 1997;69(21):4476-81doi: 10.1021/ac970364i.
Seppi, T., Stubauer, G., Obendorf, D., & Lukas, P. (1997). Direct determination of oxygen by HPLC. 2. Chamber and sample application system for determination of o(2) at trace levels. Analytical chemistry, 69(21), 4476-81. https://doi.org/10.1021/ac970364i
Seppi, T, et al. "Direct determination of oxygen by HPLC. 2. Chamber and sample application system for determination of o(2) at trace levels." Analytical chemistry vol. 69,21 (1997): 4476-81. doi: https://doi.org/10.1021/ac970364i
Seppi T, Stubauer G, Obendorf D, Lukas P. Direct determination of oxygen by HPLC. 2. Chamber and sample application system for determination of o(2) at trace levels. Anal Chem. 1997 Nov 01;69(21):4476-81. doi: 10.1021/ac970364i. PMID: 21639180.
Copy Download .nbib Format: NLM
Proposed neuroimaging criteria for the diagnosis of multiple system atrophy.

Movement disorders : official journal of the Movement Disorder Society

Brooks DJ, Seppi K.
PMID: 19306362
Mov Disord. 2009 May 15;24(7):949-64. doi: 10.1002/mds.22413.

In this article, we review the state of the art knowledge concerning structural and functional imaging in multiple system atrophy (MSA). The relative value of imaging modalities in the differential diagnosis of MSA from other parkinsonian syndromes is debated....

Cite
Brooks DJ, Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord. 2009;24(7):949-64doi: 10.1002/mds.22413.
Brooks, D. J., Seppi, K. (2009). Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society, 24(7), 949-64. https://doi.org/10.1002/mds.22413
Brooks, David J, et al. "Proposed neuroimaging criteria for the diagnosis of multiple system atrophy." Movement disorders : official journal of the Movement Disorder Society vol. 24,7 (2009): 949-64. doi: https://doi.org/10.1002/mds.22413
Brooks DJ, Seppi K. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov Disord. 2009 May 15;24(7):949-64. doi: 10.1002/mds.22413. PMID: 19306362.
Copy Download .nbib Format: NLM
Regulation of sphingolipid biosynthesis by the morphogenesis checkpoint kinase Swe1.

The Journal of biological chemistry

Chauhan N, Han G, Somashekarappa N, Gable K, Dunn T, Kohlwein SD.
PMID: 28576886
J Biol Chem. 2017 Jun 02;292(22):9431. doi: 10.1074/jbc.A115.693200.

No abstract available.

Cite
Chauhan N, Han G, Somashekarappa N, et al. Regulation of sphingolipid biosynthesis by the morphogenesis checkpoint kinase Swe1. J Biol Chem. 2017;292(22):9431doi: 10.1074/jbc.A115.693200.
Chauhan, N., Han, G., Somashekarappa, N., Gable, K., Dunn, T., & Kohlwein, S. D. (2017). Regulation of sphingolipid biosynthesis by the morphogenesis checkpoint kinase Swe1. The Journal of biological chemistry, 292(22), 9431. https://doi.org/10.1074/jbc.A115.693200
Chauhan, Neha, et al. "Regulation of sphingolipid biosynthesis by the morphogenesis checkpoint kinase Swe1." The Journal of biological chemistry vol. 292,22 (2017): 9431. doi: https://doi.org/10.1074/jbc.A115.693200
Chauhan N, Han G, Somashekarappa N, Gable K, Dunn T, Kohlwein SD. Regulation of sphingolipid biosynthesis by the morphogenesis checkpoint kinase Swe1. J Biol Chem. 2017 Jun 02;292(22):9431. doi: 10.1074/jbc.A115.693200. PMID: 28576886; PMCID: PMC5454121.
Copy Download .nbib Format: NLM
Aged Yeast Mother Cells Show Markers of Apoptosis.

TheScientificWorldJournal

Laun P, Pichova A, Madeo F, Ellinger A, Kohlwein SD, Froumlhlich KU, Dawes I, Breitenbach M.
PMID: 30147618
ScientificWorldJournal. 2001 Dec 12;1:141. doi: 10.1100/tsw.2001.238. eCollection 2001.

No abstract available.

Cite
Laun P, Pichova A, Madeo F, et al. Aged Yeast Mother Cells Show Markers of Apoptosis. ScientificWorldJournal. 2001;1:141doi: 10.1100/tsw.2001.238.
Laun, P., Pichova, A., Madeo, F., Ellinger, A., Kohlwein, S. D., Froumlhlich, K. U., Dawes, I., & Breitenbach, M. (2001). Aged Yeast Mother Cells Show Markers of Apoptosis. TheScientificWorldJournal, 1141. https://doi.org/10.1100/tsw.2001.238
Laun, Peter, et al. "Aged Yeast Mother Cells Show Markers of Apoptosis." TheScientificWorldJournal vol. 1 (2001): 141. doi: https://doi.org/10.1100/tsw.2001.238
Laun P, Pichova A, Madeo F, Ellinger A, Kohlwein SD, Froumlhlich KU, Dawes I, Breitenbach M. Aged Yeast Mother Cells Show Markers of Apoptosis. ScientificWorldJournal. 2001 Dec 12;1:141. doi: 10.1100/tsw.2001.238. eCollection 2001. PMID: 30147618; PMCID: PMC6084138.
Copy Download .nbib Format: NLM
Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes.

Movement disorders clinical practice

Reiter E, Heim B, Scherfler C, Mueller C, Nocker M, Ndayisaba JP, Loescher W, Seppi K, Lees AJ, Warner T, Poewe W, Wenning GK, Djamshidian A.
PMID: 30713929
Mov Disord Clin Pract. 2016 Jan 18;3(4):382-388. doi: 10.1002/mdc3.12301. eCollection 2016.

BACKGROUND: Cerebral hemiatrophy syndromes can present with variable neurological symptoms. In childhood epilepsy, mental retardation and neuropsychiatric disorders are common while in adults movement disorders, such as highly asymmetric parkinsonism or hemidystonia as well as neuropsychiatric problems have been...

Cite
Reiter E, Heim B, Scherfler C, et al. Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes. Mov Disord Clin Pract. 2016;3(4):382-388doi: 10.1002/mdc3.12301.
Reiter, E., Heim, B., Scherfler, C., Mueller, C., Nocker, M., Ndayisaba, J. P., Loescher, W., Seppi, K., Lees, A. J., Warner, T., Poewe, W., Wenning, G. K., & Djamshidian, A. (2016). Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes. Movement disorders clinical practice, 3(4), 382-388. https://doi.org/10.1002/mdc3.12301
Reiter, Eva, et al. "Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes." Movement disorders clinical practice vol. 3,4 (2016): 382-388. doi: https://doi.org/10.1002/mdc3.12301
Reiter E, Heim B, Scherfler C, Mueller C, Nocker M, Ndayisaba JP, Loescher W, Seppi K, Lees AJ, Warner T, Poewe W, Wenning GK, Djamshidian A. Clinical Heterogeneity in Cerebral Hemiatrophy Syndromes. Mov Disord Clin Pract. 2016 Jan 18;3(4):382-388. doi: 10.1002/mdc3.12301. eCollection 2016. PMID: 30713929; PMCID: PMC6353474.
Copy Download .nbib Format: NLM
Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System.

Alzheimer's & dementia (Amsterdam, Netherlands)

van Eimeren T, Antonini A, Berg D, Bohnen N, Ceravolo R, Drzezga A, Höglinger GU, Higuchi M, Lehericy S, Lewis S, Monchi O, Nestor P, Ondrus M, Pavese N, Peralta MC, Piccini P, Pineda-Pardo JÁ, Rektorová I, Rodríguez-Oroz M, Rominger A, Seppi K, Stoessl AJ, Tessitore A, Thobois S, Kaasinen V, Wenning G, Siebner HR, Strafella AP, Rowe JB.
PMID: 30984816
Alzheimers Dement (Amst). 2019 Apr 02;11:301-309. doi: 10.1016/j.dadm.2019.01.011. eCollection 2019 Dec.

INTRODUCTION: Therapeutic strategies targeting protein aggregations are ready for clinical trials in atypical parkinsonian disorders. Therefore, there is an urgent need for neuroimaging biomarkers to help with the early detection of neurodegenerative processes, the early differentiation of the underlying...

Cite
van Eimeren T, Antonini A, Berg D, et al. Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimers Dement (Amst). 2019;11:301-309doi: 10.1016/j.dadm.2019.01.011.
van Eimeren, T., Antonini, A., Berg, D., Bohnen, N., Ceravolo, R., Drzezga, A., Höglinger, G. U., Higuchi, M., Lehericy, S., Lewis, S., Monchi, O., Nestor, P., Ondrus, M., Pavese, N., Peralta, M. C., Piccini, P., Pineda-Pardo, J. �. �., Rektorová, I., Rodríguez-Oroz, M., Rominger, A., Seppi, K., Stoessl, A. J., Tessitore, A., Thobois, S., Kaasinen, V., Wenning, G., Siebner, H. R., Strafella, A. P., & Rowe, J. B. (2019). Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimer's & dementia (Amsterdam, Netherlands), 11301-309. https://doi.org/10.1016/j.dadm.2019.01.011
van Eimeren, Thilo, et al. "Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System." Alzheimer's & dementia (Amsterdam, Netherlands) vol. 11 (2019): 301-309. doi: https://doi.org/10.1016/j.dadm.2019.01.011
van Eimeren T, Antonini A, Berg D, Bohnen N, Ceravolo R, Drzezga A, Höglinger GU, Higuchi M, Lehericy S, Lewis S, Monchi O, Nestor P, Ondrus M, Pavese N, Peralta MC, Piccini P, Pineda-Pardo JÁ, Rektorová I, Rodríguez-Oroz M, Rominger A, Seppi K, Stoessl AJ, Tessitore A, Thobois S, Kaasinen V, Wenning G, Siebner HR, Strafella AP, Rowe JB. Neuroimaging biomarkers for clinical trials in atypical parkinsonian disorders: Proposal for a Neuroimaging Biomarker Utility System. Alzheimers Dement (Amst). 2019 Apr 02;11:301-309. doi: 10.1016/j.dadm.2019.01.011. eCollection 2019 Dec. PMID: 30984816; PMCID: PMC6446052.
Copy Download .nbib Format: NLM
Characterization and diagnostic potential of diffusion tractography in multiple system atrophy.

Parkinsonism & related disorders

Beliveau V, Krismer F, Skalla E, Schocke MM, Gizewski ER, Wenning GK, Poewe W, Seppi K, Scherfler C.
PMID: 33713904
Parkinsonism Relat Disord. 2021 Apr;85:30-36. doi: 10.1016/j.parkreldis.2021.02.027. Epub 2021 Mar 03.

INTRODUCTION: Microstructural integrity of the middle cerebellar peduncle (MCP) and the putamen captured by diffusion-tensor imaging (DTI) is differentially affected in the parkinsonian and cerebellar variants of multiple system atrophy (MSA-P, MSA-C) compared to Parkinson's disease (PD). The current...

Cite
Beliveau V, Krismer F, Skalla E, et al. Characterization and diagnostic potential of diffusion tractography in multiple system atrophy. Parkinsonism Relat Disord. 2021;85:30-36doi: 10.1016/j.parkreldis.2021.02.027.
Beliveau, V., Krismer, F., Skalla, E., Schocke, M. M., Gizewski, E. R., Wenning, G. K., Poewe, W., Seppi, K., & Scherfler, C. (2021). Characterization and diagnostic potential of diffusion tractography in multiple system atrophy. Parkinsonism & related disorders, 8530-36. https://doi.org/10.1016/j.parkreldis.2021.02.027
Beliveau, Vincent, et al. "Characterization and diagnostic potential of diffusion tractography in multiple system atrophy." Parkinsonism & related disorders vol. 85 (2021): 30-36. doi: https://doi.org/10.1016/j.parkreldis.2021.02.027
Beliveau V, Krismer F, Skalla E, Schocke MM, Gizewski ER, Wenning GK, Poewe W, Seppi K, Scherfler C. Characterization and diagnostic potential of diffusion tractography in multiple system atrophy. Parkinsonism Relat Disord. 2021 Apr;85:30-36. doi: 10.1016/j.parkreldis.2021.02.027. Epub 2021 Mar 03. PMID: 33713904.
Copy Download .nbib Format: NLM
Effects of structured home-based exercise training on circulating endothelial progenitor cells and endothelial function in patients with intermittent claudication.

Vascular medicine (London, England)

Pasqualini L, Bagaglia F, Ministrini S, Frangione MR, Leli C, Siepi D, Lombardini R, Marini E, Naeimi Kararoudi M, Piratinskiy A, Pirro M.
PMID: 34151646
Vasc Med. 2021 Dec;26(6):633-640. doi: 10.1177/1358863X211020822. Epub 2021 Jun 21.

INTRODUCTION: Exercise training improves walking capacity in patients with intermittent claudication (IC). Endothelial progenitor cells (EPCs), endothelial microparticles (EMPs), and endothelial dysfunction could play a role in this process.METHODS: We measured EPCs and EMPs in a group of 60...

Cite
Pasqualini L, Bagaglia F, Ministrini S, et al. Effects of structured home-based exercise training on circulating endothelial progenitor cells and endothelial function in patients with intermittent claudication. Vasc Med. 2021;26(6):633-640doi: 10.1177/1358863X211020822.
Pasqualini, L., Bagaglia, F., Ministrini, S., Frangione, M. R., Leli, C., Siepi, D., Lombardini, R., Marini, E., Naeimi Kararoudi, M., Piratinskiy, A., & Pirro, M. (2021). Effects of structured home-based exercise training on circulating endothelial progenitor cells and endothelial function in patients with intermittent claudication. Vascular medicine (London, England), 26(6), 633-640. https://doi.org/10.1177/1358863X211020822
Pasqualini, Leonella, et al. "Effects of structured home-based exercise training on circulating endothelial progenitor cells and endothelial function in patients with intermittent claudication." Vascular medicine (London, England) vol. 26,6 (2021): 633-640. doi: https://doi.org/10.1177/1358863X211020822
Pasqualini L, Bagaglia F, Ministrini S, Frangione MR, Leli C, Siepi D, Lombardini R, Marini E, Naeimi Kararoudi M, Piratinskiy A, Pirro M. Effects of structured home-based exercise training on circulating endothelial progenitor cells and endothelial function in patients with intermittent claudication. Vasc Med. 2021 Dec;26(6):633-640. doi: 10.1177/1358863X211020822. Epub 2021 Jun 21. PMID: 34151646.
Copy Download .nbib Format: NLM
Factors associated with augmentation in patients with restless legs syndrome.

European journal of neurology

Heim B, Ellmerer P, Stefani A, Bergmann M, Brandauer E, Seppi K, Högl B, Djamshidian A.
PMID: 34923723
Eur J Neurol. 2021 Dec 18; doi: 10.1111/ene.15221. Epub 2021 Dec 18.

BACKGROUND AND PURPOSE: Augmentation is a paradoxical reaction mainly to dopaminergic medication in patients with restless legs syndrome (RLS), but the exact pathomechanism remains unclear. The aim of this study was to identify factors associated with augmentation in RLS...

Cite
Heim B, Ellmerer P, Stefani A, et al. Factors associated with augmentation in patients with restless legs syndrome. Eur J Neurol. 2021;doi: 10.1111/ene.15221.
Heim, B., Ellmerer, P., Stefani, A., Bergmann, M., Brandauer, E., Seppi, K., Högl, B., & Djamshidian, A. (2021). Factors associated with augmentation in patients with restless legs syndrome. European journal of neurology, . https://doi.org/10.1111/ene.15221
Heim, Beatrice, et al. "Factors associated with augmentation in patients with restless legs syndrome." European journal of neurology vol. (2021). doi: https://doi.org/10.1111/ene.15221
Heim B, Ellmerer P, Stefani A, Bergmann M, Brandauer E, Seppi K, Högl B, Djamshidian A. Factors associated with augmentation in patients with restless legs syndrome. Eur J Neurol. 2021 Dec 18; doi: 10.1111/ene.15221. Epub 2021 Dec 18. PMID: 34923723.
Copy Download .nbib Format: NLM
Impact of COVID-19 on Radiation Oncology, an Austrian Experience.

Current oncology (Toronto, Ont.)

Mangesius J, Arnold CR, Seppi T, Mangesius S, Brüggl M, Eichberger P, Ganswindt U.
PMID: 34898552
Curr Oncol. 2021 Nov 17;28(6):4776-4785. doi: 10.3390/curroncol28060404.

The COVID-19 pandemic has an unprecedented impact on cancer treatment worldwide. We aimed to evaluate the effects of the pandemic on the radiation treatment of patients in order to provide data for future management of such crises. We compared...

Cite
Mangesius J, Arnold CR, Seppi T, et al. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Curr Oncol. 2021;28(6):4776-4785doi: 10.3390/curroncol28060404.
Mangesius, J., Arnold, C. R., Seppi, T., Mangesius, S., Brüggl, M., Eichberger, P., & Ganswindt, U. (2021). Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Current oncology (Toronto, Ont.), 28(6), 4776-4785. https://doi.org/10.3390/curroncol28060404
Mangesius, Julian, et al. "Impact of COVID-19 on Radiation Oncology, an Austrian Experience." Current oncology (Toronto, Ont.) vol. 28,6 (2021): 4776-4785. doi: https://doi.org/10.3390/curroncol28060404
Mangesius J, Arnold CR, Seppi T, Mangesius S, Brüggl M, Eichberger P, Ganswindt U. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Curr Oncol. 2021 Nov 17;28(6):4776-4785. doi: 10.3390/curroncol28060404. PMID: 34898552; PMCID: PMC8628691.
Copy Download .nbib Format: NLM
Impact of COVID-19 on Radiation Oncology, an Austrian Experience.

Current oncology (Toronto, Ont.)

Mangesius J, Arnold CR, Seppi T, Mangesius S, Brüggl M, Eichberger P, Ganswindt U.
PMID: 34898552
Curr Oncol. 2021 Nov 17;28(6):4776-4785. doi: 10.3390/curroncol28060404.

The COVID-19 pandemic has an unprecedented impact on cancer treatment worldwide. We aimed to evaluate the effects of the pandemic on the radiation treatment of patients in order to provide data for future management of such crises. We compared...

Cite
Mangesius J, Arnold CR, Seppi T, et al. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Curr Oncol. 2021;28(6):4776-4785doi: 10.3390/curroncol28060404.
Mangesius, J., Arnold, C. R., Seppi, T., Mangesius, S., Brüggl, M., Eichberger, P., & Ganswindt, U. (2021). Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Current oncology (Toronto, Ont.), 28(6), 4776-4785. https://doi.org/10.3390/curroncol28060404
Mangesius, Julian, et al. "Impact of COVID-19 on Radiation Oncology, an Austrian Experience." Current oncology (Toronto, Ont.) vol. 28,6 (2021): 4776-4785. doi: https://doi.org/10.3390/curroncol28060404
Mangesius J, Arnold CR, Seppi T, Mangesius S, Brüggl M, Eichberger P, Ganswindt U. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Curr Oncol. 2021 Nov 17;28(6):4776-4785. doi: 10.3390/curroncol28060404. PMID: 34898552; PMCID: PMC8628691.
Copy Download .nbib Format: NLM
Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study.

European urology oncology

Rocco B, Sighinolfi MC, Sandri M, Spandri V, Cimadamore A, Volavsek M, Mazzucchelli R, Lopez-Beltran A, Eissa A, Bertoni L, Azzoni P, Reggiani Bonetti L, Maiorana A, Puliatti S, Micali S, Paterlini M, Iseppi A, Rocco F, Pellacani G, Chester J, Bianchi G, Montironi R.
PMID: 32952095
Eur Urol Oncol. 2021 Oct;4(5):784-791. doi: 10.1016/j.euo.2020.08.009. Epub 2020 Sep 18.

BACKGROUND: A microscopic analysis of tissue is the gold standard for cancer detection. Hematoxylin-eosin (HE) for the reporting of prostate biopsy (PB) is conventionally based on fixation, processing, acquisition of glass slides, and analysis with an analog microscope by...

Cite
Rocco B, Sighinolfi MC, Sandri M, et al. Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study. Eur Urol Oncol. 2020;4(5):784-791doi: 10.1016/j.euo.2020.08.009.
Rocco, B., Sighinolfi, M. C., Sandri, M., Spandri, V., Cimadamore, A., Volavsek, M., Mazzucchelli, R., Lopez-Beltran, A., Eissa, A., Bertoni, L., Azzoni, P., Reggiani Bonetti, L., Maiorana, A., Puliatti, S., Micali, S., Paterlini, M., Iseppi, A., Rocco, F., Pellacani, G., Chester, J., Bianchi, G., & Montironi, R. (2021). Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study. European urology oncology, 4(5), 784-791. https://doi.org/10.1016/j.euo.2020.08.009
Rocco, Bernardo, et al. "Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study." European urology oncology vol. 4,5 (2021): 784-791. doi: https://doi.org/10.1016/j.euo.2020.08.009
Rocco B, Sighinolfi MC, Sandri M, Spandri V, Cimadamore A, Volavsek M, Mazzucchelli R, Lopez-Beltran A, Eissa A, Bertoni L, Azzoni P, Reggiani Bonetti L, Maiorana A, Puliatti S, Micali S, Paterlini M, Iseppi A, Rocco F, Pellacani G, Chester J, Bianchi G, Montironi R. Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study. Eur Urol Oncol. 2021 Oct;4(5):784-791. doi: 10.1016/j.euo.2020.08.009. Epub 2020 Sep 18. PMID: 32952095.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 76 entries